SOF/VEL in Patients Aged 6-18 Years With Chronic HCV SOF/VEL in Patients Aged 6-18 Years With Chronic HCV
This real-world study found sofosbuvir/velpatasvir 100% effective in a pediatric population with chronic hepatitis C, with no serious adverse effects.Liver International
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
More News: Gastroenterology | Hepatitis | Hepatitis C | HIV AIDS | Infectious Diseases | Liver | Pediatrics | Study | Urology & Nephrology